Family Physician attitudes about prescribing using a drug formulary
Open Access
- 16 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Family Practice
- Vol. 10 (1), 69
- https://doi.org/10.1186/1471-2296-10-69
Abstract
Background Drug formularies have been created by third party payers to control prescription drug usage and manage costs. Physicians try to provide the best care for their patients. This research examines family physicians' attitudes regarding prescription reimbursement criteria, prescribing and advocacy for patients experiencing reimbursement barriers. Methods Focus groups were used to collect qualitative data on family physicians' prescribing decisions related to drug reimbursement guidelines. Forty-eight family physicians from four Ontario cities participated. Ethics approval for this study was received from the Hamilton Health Sciences/Faculty of Health Sciences Research Ethics Board at McMaster University. Four clinical scenarios were used to situate and initiate focus group discussions about prescribing decisions. Open-ended questions were used to probe physicians' experiences and attitudes and responses were audio recorded. NVivo software was used to assist in data analysis. Results Most physicians reported that drug reimbursement guidelines complicated their prescribing process and can require lengthy interpretation and advocacy for patients who require medication that is subject to reimbursement restrictions. Conclusion Physicians do not generally see their role as being cost-containment monitors and observed that cumbersome reimbursement guidelines influence medication choice beyond the clinical needs of the patient, and produce unequal access to medication. They observed that frustration, discouragement, fatigue, and lack of appreciation can often contribute to family physicians' failure to advocate more for patients. Physicians argue cumbersome reimbursement regulations contribute to lower quality care and misuse of physicians' time increasing overall health care costs by adding unnecessary visits to family physicians, specialists, and emergency rooms.Keywords
This publication has 19 references indexed in Scilit:
- Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in OntarioHealthcare Policy, 2007
- Physician Awareness of Drug Cost: A Systematic ReviewPLoS Medicine, 2007
- Promise and Perils for Patients and PhysiciansThe New England Journal of Medicine, 2005
- The new medicare drug benefit: formularies and their potential effects on access to medications.Published by Emerald ,2005
- The new medicare drug benefit: Formularies and their potential effects on access to medicationsJournal of General Internal Medicine, 2005
- Incorporating Economic Evaluations Into Decision-MakingMedical Care, 2005
- Barriers to patient-physician communication about out-of-pocket costsJournal of General Internal Medicine, 2004
- Physicians’ Views Of Formularies: Implications For Medicare Drug Benefit DesignHealth Affairs, 2004
- Patient-Physician Communication About Out-of-Pocket CostsJAMA, 2003
- Whither Seniors’ Pharmacare: Lessons From (And For) CanadaHealth Affairs, 2003